Alexander V Veselovsky
Overview
Explore the profile of Alexander V Veselovsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasaev S, Mukanov A, Mishkorez I, Kuznetsov I, Leibin I, Dolgusheva V, et al.
Biochemistry (Mosc)
. 2024 Sep;
89(8):1451-1473.
PMID: 39245455
High-affinity and specific agents are widely applied in various areas, including diagnostics, scientific research, and disease therapy (as drugs and drug delivery systems). It takes significant time to develop them....
2.
Schimunek J, Seidl P, Elez K, Hempel T, Le T, Noe F, et al.
Mol Inform
. 2023 Oct;
43(1):e202300262.
PMID: 37833243
The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient...
3.
Nasaev S, Mukanov A, Kuznetsov I, Veselovsky A
Mol Inform
. 2023 Sep;
42(12):e202300113.
PMID: 37710142
Nowadays there are numerous discovered natural RNA variations participating in different cellular processes and artificial RNA, e. g., aptamers, riboswitches. One of the required tasks in the investigation of their...
4.
Latysheva A, Zolottsev V, Veselovsky A, Scherbakov K, Morozevich G, Zhdanov D, et al.
J Steroid Biochem Mol Biol
. 2023 Mar;
230:106280.
PMID: 36870373
Steroid derivatives modified with nitrogen containing heterocycles are known to inhibit activity of steroidogenic enzymes, decrease proliferation of cancer cells and attract attention as promising anticancer agents. Specifically, 2'-(3β-hydroxyandrosta-5,16-dien-17-yl)-4',5'-dihydro-1',3'-oxazole 1a...
5.
Zernov N, Veselovsky A, Poroikov V, Melentieva D, Bolshakova A, Popugaeva E
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362339
Synapse loss in the brain of Alzheimer's disease patients correlates with cognitive dysfunctions. Drugs that limit synaptic loss are promising pharmacological agents. The transient receptor potential cation channel, subfamily C,...
6.
Shumyantseva V, Koroleva P, Bulko T, Shkel T, Gilep A, Veselovsky A
Bioelectrochemistry
. 2022 Oct;
149:108277.
PMID: 36198256
The electrochemically driven cytochrome P450 reactions have great promise as drug sensing device, new drug searching tool and bioreactor with broad synthetic application. In the present work, we proposed approaches...
7.
Tawfik H, El-Hamaky A, El-Bastawissy E, Shcherbakov K, Veselovsky A, Gladilina Y, et al.
Pharmaceuticals (Basel)
. 2022 Apr;
15(4).
PMID: 35455478
Telomeres serve a critical function in cell replication and proliferation at every stage of the cell cycle. Telomerase is a ribonucleoprotein, responsible for maintaining the telomere length and chromosomal integrity...
8.
Plyasova A, Berrino E, Khan I, Veselovsky A, Pokrovsky V, Angeli A, et al.
J Med Chem
. 2021 Jul;
64(15):11432-11444.
PMID: 34283610
Human (h) telomerase (TL; EC 2.7.7.49) plays a key role in sustaining cancer cells by means of elongating telomeric repeats at the 3' ends of chromosomes. Since TL-inhibitor (TI) stand-alone...
9.
Ershov P, Veselovsky A, Mezentsev Y, Yablokov E, Kaluzhskiy L, Tumilovich A, et al.
Int J Mol Sci
. 2020 Oct;
21(20).
PMID: 33066693
Isatin (indole-2, 3-dione) is a non-peptide endogenous bioregulator exhibiting a wide spectrum of biological activity, realized in the cell via interactions with numerous isatin-binding proteins, their complexes, and (sub) interactomes....
10.
Masamrekh R, Filippova T, Sherbakov K, Veselovsky A, Shumyantseva V, Kuzikov A
Fundam Clin Pharmacol
. 2020 Oct;
35(2):423-431.
PMID: 33012006
We have investigated interactions of galeterone and its pharmacologically active metabolite - 3-keto-Δ4-galeterone (D4G) - with one of the key enzymes of corticosteroid biosynthesis - steroid 21-monooxygenase (CYP21A2). It was...